ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683856 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683856; 2) Community: the network communities that were significantly associated with the response to NSC 683856; 3) Molecule: the relationships between components within communities and NSC 683856; 4) MDR: the compounds that were significantly associated with the NSC 683856.

NSC Compound Enrichment Correlation
NSC 626030 Naphth[2,3-d]oxazol-4-one, 2-(1,1-dimethylethyl)-9-[(4- fluorophenyl)imino]- 0.0246753314031139 -0.3464341
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0246753314031139 0.21117185
NSC 644902 Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 0.0246753314031139 -0.36358041
NSC 665700 Null 0.0246753314031139 -0.27765116
NSC 682756 Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- 0.0246753314031139 0.39656043
NSC 113053 Null 0.0252510646170343 -0.048683062
NSC 135758 Piperazinedione 0.0252510646170343 0.16348908
NSC 160121 1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride 0.0252510646170343 -0.0020655323
NSC 287459 Cytarabine AY 0.0252510646170343 0.21599426
NSC 287513 Ametantrone acetate 0.0252510646170343 0.18999251
Total:59  Current:28    [First] [Prev] [Next] [Last]